DIULO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diulo, and when can generic versions of Diulo launch?
Diulo is a drug marketed by Gd Searle Llc and is included in one NDA.
The generic ingredient in DIULO is metolazone. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diulo
A generic version of DIULO was approved as metolazone by SANDOZ on December 19th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIULO?
- What are the global sales for DIULO?
- What is Average Wholesale Price for DIULO?
Summary for DIULO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Patent Applications: | 4,511 |
| DailyMed Link: | DIULO at DailyMed |
US Patents and Regulatory Information for DIULO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | DIULO | metolazone | TABLET;ORAL | 018535-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | DIULO | metolazone | TABLET;ORAL | 018535-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gd Searle Llc | DIULO | metolazone | TABLET;ORAL | 018535-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
